Este sitio web fue traducido automáticamente. Para obtener más información, por favor haz clic aquí.
Join Fox News for access to this content
Plus special access to select articles and other premium content with your account - free of charge.
By entering your email and pushing continue, you are agreeing to Fox News' Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.
Please enter a valid email address.
By entering your email and pushing continue, you are agreeing to Fox News' Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

The Biden administration appears to have intervened in a supposedly nonpartisan science review, manufacturing a paper trail in support of its environmental justice efforts targeting a major chemical plant, according to court filings reviewed by Fox News Digital.

In stunning testimony late last year, Michael Morton — who serves as the Environmental Protection Agency (EPA) Region 6 science liaison to the EPA Office of Research and Development (ORD) in Washington, D.C. — admitted that he didn't author a key July 2021 email sent from his email address. That email called off a scientific review of health risks associated with chloroprene emissions which are at the center of an ongoing federal lawsuit with vast economic implications.

"I didn't write that," Morton told lawyers for synthetics manufacturer Denka Performance Elastomer (DPE) during a deposition in November. "I didn't say that. For – for that part, I didn't – I don't know that, so I don't know who wrote that," he added when pressed on the email.

Morton's testimony and revelations from additional information made public in recent months may ultimately derail the Biden administration's lawsuit against DPE which, if successful, could threaten the future operations of the company's major manufacturing facility in LaPlace, Louisiana, and further set a precedent broadly threatening the multi-billion-dollar U.S. petrochemical industry

REPUBLICAN STATE SUES BIDEN ADMIN OVER ENVIRONMENTAL JUSTICE ACTIONS: 'DYSTOPIAN NIGHTMARE'

The Denka, formerly DuPont, factory in Reserve, Louisiana, on August 12, 2021. - Silos, smokestacks and brown pools of water line the banks of the Mississippi River in Louisiana, where scores of refineries and petrochemical plants have metastasized over a few decades. Welcome to "Cancer Alley." Industrial pollution on this ribbon of land between New Orleans and Baton Rouge puts the mostly African-American residents at nearly 50 times the risk of developing cancer than the national average, according to the US Environmental Protection Agency (EPA). (Photo by Emily Kask / AFP) (Photo by EMILY KASK/AFP via Getty Images)

The Denka Performance Elastomer facility in LaPlace, Louisiana, is pictured on Aug. 12, 2021. The plant is the only U.S. plant to produce neoprene, a synthetic rubber common in military equipment, wetsuits and medical technology. (EMILY KASK/AFP via Getty Images)

In February 2023, the Department of Justice filed a federal lawsuit against DPE on behalf of EPA, seeking to compel the chemical maker's LaPlace facility — the so-called Pontchartrain Works Site which represents the only U.S. plant to produce neoprene, a synthetic rubber common in military equipment, wetsuits and medical technology — to reduce emissions of chloroprene. Chloroprene is a liquid raw material emitted during neoprene manufacturing.

According to the lawsuit, the plant's emissions pose a cancer risk to residents in Saint John the Baptist Parish, Louisiana, and therefore present an "imminent and substantial endangerment to public health and welfare."

WHITE HOUSE SILENT AS OIL PRODUCTION REACHES RECORD, ENVIRONMENTALISTS CALL FOR GREEN ENERGY

"When I visited Saint John the Baptist Parish during my first Journey to Justice tour, I pledged to the community that EPA would take strong action to protect the health and safety of families from harmful chloroprene emissions from the Denka facility," EPA Administrator Michael Regan said after the lawsuit was filed, adding that DPE hasn't "moved far enough or fast enough" to reduce emissions.

Less than one month later, the Justice Department filed a motion for preliminary injunction in the case, essentially asking the court to enforce a shutdown of DPE's neoprene facility if the company failed to immediately implement substantial emissions reductions. Assistant Attorney General Todd Kim said the motion "shows our determination to address environmental justice concerns."

Michael Regan

Environmental Protection Agency Administrator Michael Regan addresses the press in East Palestine, Ohio, last year. (AP Photo/Matt Freed)

DPE said in a response motion months later that the federal government's actions are "tantamount to a shutdown order that would have catastrophic consequences for DPE," adding that it would lead to "complete loss of revenue streams, substantial loss of work force, supply chain disruptions and contractual impacts, and regulatory challenges."

The company also characterized the Biden administration's efforts against it as politically driven, unsupported by real-world science, and outside its legal authority under the Clean Air Act. DPE pointed to how its LaPlace facility has sharply curbed its chloroprene emissions and complied with environmental permits.

DPE also pointed to Louisiana Tumor Registry data showing that St. John the Baptist Parish, the region where its neoprene facility is located, has recorded one of the lowest cancer rates of any region in the state.

ALASKAN NATIVE AMERICANS UNLEASH ON BIDEN ADMIN'S CLIMATE AGENDA: 'COMMUNITIES AND CULTURE ARE AT RISK'

And, notably, DPE has criticized EPA for basing its lawsuit largely on a study the agency published in 2010 concluding chloroprene is "likely to be carcinogenic to humans." That study, which itself cites 25-year-old studies of female mice, led to the strict emissions standard of 0.2 micrograms of chloroprene per cubic meter air that the EPA is seeking to enforce on DPE's facility in LaPlace.

DPE and Lousiana lawmakers have for years sought EPA action to reassess that tight standard, arguing in favor of additional study and scientific review, arguing the 2010 study overestimated chloroprene's cancer risk to humans.

Joe Biden, Michael Regan

President Biden talks to EPA Administrator Regan during an environmental justice event at the White House last year. (Drew Angerer/Getty Images)

The EPA appeared to relent in April 2021 when its Region 6 branch based in Texas, but covering Louisiana and other southern states, nominated chloroprene for a review to revisit its assessment of the chemical's health risks. But EPA's ORD office eventually refused to pursue the review, citing the July 2021 email from Morton, the Region 6 science liaison who recently testified he didn't pen that email.

"We continue to seek additional chloroprene emission reductions from the DPE facility in LaPlace, Louisiana in order to continue to reduce the risks that chloroprene emissions from the DPE facility present to the surrounding community," read Morton's email, which was sent to senior EPA ORD official Kris Thayer.

"The cancer inhalation risk estimate is among the factors that the EPA and Louisiana DEQ are using to determine the extent of additional emission reductions needed from the DPE facility," it concluded.

TOP HOUSE COMMITTEE PROBES JOHN KERRY'S COORDINATION WITH ECO GROUPS PUSHING COAL POWER SHUTDOWN

In addition to Morton's testimony, DPE counsel submitted in court filings metadata of his email showing it was originally authored by ORD officials.

Metadata of EPA Region 6 official Michael Morton's 2021 email walking back his office's nomination of chloroprene. The metadata shows the email was authored by EPA ORD official Dahnish Shams.

Metadata of EPA Region 6 official Michael Morton's 2021 email walking back his office's nomination of chloroprene. The metadata shows Morton's email was authored by EPA ORD official Dahnish Shams. (United States District Court for the Eastern District of Louisiana)

The revelations suggest that, to walk back the nomination of chloroprene, ORD cited an email purportedly from Region 6, but which it appears to have actually crafted and sent to itself using Morton's email address. 

If EPA had moved forward with the nomination of chloroprene and engaged with new research, though, its eventual lawsuit targeting DPE's LaPlace facility may have been derailed.

EPA declined to comment, citing its policy against commenting on pending litigation. 

CLICK HERE TO GET THE FOX NEWS APP

Overall, the multi-billion-dollar petrochemical industry in Louisiana is a key driver of jobs and investment in the state. The industry is also a central reason why the state is the third-largest consumer of petroleum and largest consumer of petroleum per capita in the nation, according to the Energy Information Administration.

However, the petrochemical industry has long been target of environmentalists who argue it is responsible for harmful emissions and pollution negatively impacting surrounding communities' health.